Anti-CD20 antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphoma
Authors:
- 4 May 2005
- journal article
- letter
- Published by Springer Nature in Annals of Hematology
- Vol. 84 (8) , 548-550
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Rituximab: Expanding Role in Therapy for Lymphomas and Autoimmune DiseasesAnnual Review of Medicine, 2004
- Successful treatment of refractory myasthenia gravis using rituximab: a pediatric case reportThe Journal of Pediatrics, 2003
- Rituximab therapy and autoimmune disorders: Prospects for anti–B cell therapyArthritis & Rheumatism, 2003